Cargando…
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
Currently, there is no cure for chronic obstructive pulmonary disease (COPD). The limited efficacy of current therapies for COPD indicates a pressing need to develop new treatments to prevent the progression of the disease, which consumes a significant amount of health care resources and is an impor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940640/ https://www.ncbi.nlm.nih.gov/pubmed/24596460 http://dx.doi.org/10.2147/COPD.S32604 |